Herpes simplex virus 1 (HSV-1) immediate-early protein ICP0 localizes to cellular structures known as promyelocytic leukemia protein (PML) nuclear bodies or ND10 and disrupts their integrity by inducing the degradation of PML. There are six PML isoforms with different C-terminal regions in ND10, of which PML isoform I (PML.I) is the most abundant. Depletion of all PML isoforms increases the plaque formation efficiency of ICP0-null mutant HSV-1, and reconstitution of expression of PML.I and PML.II partially reverses this improved replication. ICP0 also induces widespread degradation of SUMO-conjugated proteins during HSV-1 infection, and this activity is linked to its ability to counteract cellular intrinsic antiviral resistance. All PML isoforms are highly SUMO modified, and all such modified forms are sensitive to ICP0-mediated degradation. However, in contrast to the situation with the other isoforms, ICP0 also targets PML.I that is not modified by SUMO, and PML in general is degraded more rapidly than the bulk of other SUMO-modified proteins. We report here that ICP0 interacts with PML.I in both yeast twohybrid and coimmunoprecipitation assays. This interaction is dependent on PML.I isoform-specific sequences and the N-terminal half of ICP0 and is required for SUMO-modification-independent degradation of PML.I by ICP0. Degradation of the other PML isoforms by ICP0 was less efficient in cells specifically depleted of PML.I. Therefore, ICP0 has two distinct mechanisms of targeting PML: one dependent on SUMO modification and the other via SUMO-independent interaction with PML.I. We conclude that the ICP0-PML.I interaction reflects a countermeasure to PML-related antiviral restriction. P romyelocytic leukemia protein nuclear bodies (PML-NBs), also known as ND10, are dynamic punctuate structures within the nuclei of mammalian cells that harbor a large number of permanently or transiently localized proteins (8,22,44). ND10 have been associated with many cellular functions, including DNA repair (17), regulation of transcription (42, 60), chromatin assembly and modification (18, 32), apoptosis (1, 55), stress (39), senescence (3), the ubiquitin pathway (30, 35, 36,) and oncogenesis (47, 48; reviewed in reference 2). Increasing evidence also links ND10 with an intrinsic cellular defense against many DNA viruses, such as human cytomegalovirus (HCMV), herpes simplex virus 1 (HSV-1), varicella zoster virus, human adenovirus type 5, and the murine gammaherpesvirus 68 (reviewed in references 19, 56, and 57).Very early after HSV-1 infection, the immediate-early (IE) protein ICP0 localizes to ND10 and disrupts their integrity. ICP0, which is a RING finger E3 ubiquitin ligase (7), induces the proteasome degradation of two major ND10 components, namely, PML, which is the ND10 organizer, and the small ubiquitin modifier (SUMO)-modified forms of Sp100 (5, 11, 21, 27, 41). In the absence of ICP0, PML and Sp100 are both recruited to sites associated with parental HSV-1 genomes and early replication compartments, and this behavio...